Log in
NASDAQ:SNDX

Syndax Pharmaceuticals Earnings Date, Estimates & History

$17.01
-0.05 (-0.29 %)
(As of 09/19/2020 12:28 AM ET)
Add
Compare
Today's Range
$16.51
Now: $17.01
$17.49
50-Day Range
$14.11
MA: $15.84
$17.48
52-Week Range
$5.35
Now: $17.01
$21.97
Volume1.37 million shs
Average Volume495,892 shs
Market Capitalization$655.72 million
P/E RatioN/A
Dividend YieldN/A
Beta1.77

Earnings

Syndax Pharmaceuticals (NASDAQ:SNDX) Earnings Information

Syndax Pharmaceuticals last issued its earnings data on August 6th, 2020. The reported ($0.42) EPS for the quarter, topping analysts' consensus estimates of ($0.47) by $0.05. The business had revenue of $0.38 million for the quarter. Syndax Pharmaceuticals has generated ($1.84) earnings per share over the last year. Syndax Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 5th, 2020 based off prior year's report dates.

Syndax Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Syndax Pharmaceuticals (NASDAQ:SNDX) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20201($0.97)($0.97)($0.97)
Q2 20201($0.98)($0.98)($0.98)
Q3 20201($0.89)($0.89)($0.89)

Syndax Pharmaceuticals (NASDAQ SNDX) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
11/5/2020
(Estimated)
       
8/6/20206/30/2020($0.47)($0.42)($0.42)$0.38 millionListen
5/7/2020Q1($0.51)($0.56)($0.56)$0.38 million$0.38 millionListen
3/3/202012/31/2019($0.46)($0.44)($0.44)$0.38 million$0.38 millionTranscript
11/7/2019Q3($0.48)($0.41)($0.41)$0.38 million$0.38 millionListen
8/7/2019Q2 2019($0.44)($0.47)($0.47)$0.39 million$0.38 millionN/A
5/6/20193/31/2019($0.56)($0.53)($0.53)$0.38 million$0.38 millionTranscript
3/7/201912/31/2018($0.68)($0.70)($0.70)$0.38 million$0.38 millionTranscript
11/5/20189/30/2018($0.76)($0.68)($0.68)$0.38 million$0.38 millionTranscript
8/7/2018Q2 2018($0.87)($0.74)($0.74)$0.38 million$0.38 millionN/A
5/8/2018Q1 2018($0.96)($0.79)($0.79)$0.38 millionN/A
3/5/2018Q4 2017($0.76)($0.80)($0.80)$0.75 million$1.19 millionTranscript
11/7/2017Q3 2017($0.80)($0.68)($0.68)$0.30 million$0.31 millionN/A
8/10/2017Q2 2017($0.79)($0.70)($0.70)$0.31 million$0.31 millionN/A
5/8/2017Q1 2017($0.74)($0.71)($0.71)$0.31 million$0.31 millionListen
3/2/2017Q4 2016($0.77)($0.59)($0.59)$0.31 millionListen
11/10/2016Q3 2016($0.81)($0.84)($0.84)$0.31 millionN/A
8/9/2016Q2 2016($0.53)($0.47)($0.47)$0.31 millionListen
5/16/2016Q1 2016($0.47)($2.85)($2.85)$0.31 millionListen
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 9/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.